Cathy McMorris Rodgers - 22 Jul 2025 Form 3 Insider Report for Medicus Pharma Ltd. (MDCX)

Role
Director
Signature
/s/ Raza Bokhari, as Attorney-in-Fact, for Cathy McMorris Rodgers
Issuer symbol
MDCX
Transactions as of
22 Jul 2025
Net transactions value
$0
Form type
3
Filing time
31 Jul 2025, 10:36:14 UTC
Next filing
18 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Rodgers Cathy McMorris Director 300 CONSHOHOCKEN STATE ROAD, SUITE 200, W. CONSHOHOCKEN /s/ Raza Bokhari, as Attorney-in-Fact, for Cathy McMorris Rodgers 31 Jul 2025 0002078262

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MDCX Stock Option (right to buy) 22 Jul 2025 Common Shares 25,000 $3.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on July 22, 2025. The option is scheduled to vest quarterly in four equal installments over one year.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney